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Many tumors uncouple anabolic glucose utilization from oxygen
availability to sustain unrestrained growth when oxygen and
nutrients are scarce, but the concomitant decrease in mitochondrial
respiration potentially exposes cancer cells to oxidative stress.
However, the mechanistic basis for this metabolic switch, and its
importance in the neoplastic process, has remained unclear. The
mitochondrial molecular chaperone TRAP1 is induced in most tumor
types, where it modulates both mitochondrial respiration and redox
equilibrium of neoplastic cells. TRAP1 binds to and inhibits succinate
dehydrogenase (SDH), the complex II of the respiratory chain. The
ensuing respiratory down-regulation promotes tumor growth by
minimizing oxidative damage, as it abrogates ROS generation by SDH
and the ensuing lethal opening of the mitochondrial permeability
transition pore. Moreover, TRAP1 primes the succinate-dependent
stabilization of the pro-neoplastic transcription factor HIF1. These
ﬁndings provide a mechanistic clue to explain the switch to aerobic
glycolysis of tumors, and indicate that the metabolic changes elicited by
TRAP1 are required for neoplastic growth.
doi:10.1016/j.bbabio.2014.05.002
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Altered mitochondrial bioenergetics, including dysfunction in pyru-
vate dehydrogenase (PDH) and transcriptional deregulation have been
described in Huntington's disease (HD), an autosomal dominant neuro-
degenerative disease. We previously showed that histone deacetylase
inhibitors (HDACis), which regulate transcription, positively inﬂuence
mitochondrial function in cells expressing mutant huntingtin. Thus, we
investigated the effect of the HDACis in PDH dysfunction in striatal cells
derived fromHDknock-inmice andHDYAC128mice brain.Mutant cells
exhibited decreased PDH activity and protein levels of E1alpha subunit
and increased PDH E1alpha phosphorylation/inactivation, which was
accompanied by increased protein expression of PDH kinase (PDK)1
and decreased expression of PDH phosphatase (PDP)1. Exposure to
dichloroacetate, an indirect activator of PDH, increased cell viability and
mitochondrial respiration and decreased production of reactive oxygen
species in mutant cells, emphasizing PDH as an possible therapeutic
target in HD. Treatment with sodium butyrate (SB) and phenylbutyrate,
two HDACis, increased histone H3 acetylation, recovered cell viability
and mitochondrial respiration in mutant cells. Exposure to SB also
increased PDH E1alpha subunit levels and decreased PDH phosphory-
lation in mutant cells, which was associated with decreased gene
expression of the two most abundant PDK isoforms, PDK2 and PDK3. In
accordance, YAC128 mice brain cortex presented higher mRNA levels
of PDK1-3, which were reduced following SB treatment. These results
suggest that HDACis, in particular SB, may promote the expression and
activity of PDH in HD brain, helping to counteract HD-related deﬁcits in
mitochondrial bioenergetics. Supported by Fundação para a Ciência e a
Tecnologia (FCT), Portugal, grant PTDC/SAU-FCF/108056/2008.
doi:10.1016/j.bbabio.2014.05.003
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Calcium is thought to regulate respiration but it is unclear whether
this is dependent on the increase in ATP demand caused by any Ca2+
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signal or to Ca2+ itself. [Na+]i, [Ca2+]i and [ATP]i dynamics in intact
neurons exposed to different workloads in the absence and presence of
Ca2+clearly showed that Ca2+-stimulation of coupled respiration is
required to maintain [ATP]i levels. Ca2+ may regulate respiration by
activating metabolite transport in mitochondria from outer face of the
inner mitochondrial membrane, or after Ca2+ entry in mitochondria
through the calcium uniporter (MCU). Two Ca2+-regulated mitochon-
drial metabolite transporters are expressed in neurons, the aspartate–
glutamate exchanger Aralar/AGC1/Slc25a12, a component of the
malate–aspartate shuttle, and the ATP-Mg/Pi exchanger SCaMC-3/
Slc25a23, with S0.5 for Ca2+ of 300 nM and 3.4 μM, respectively. The
lack of SCaMC-3 results in a smaller Ca2+-dependent stimulation of
respiration only at high workloads, as caused by veratridine,
whereas the lack of ARALAR reduced by 46% basal OCR in intact
neurons using glucose as energy source and the Ca2+-dependent
responses to all workloads (veratridine, K+-depolarization, carba-
chol). The lack of ARALAR caused a reduction of about 65–70% in the
response to the high workload imposed by veratridine, and
completely suppressed the OCR responses to moderate (K+-
depolarization) and small (carbachol) workloads, effects reverted
by pyruvate supply. For K+-depolarization, this occurred in spite of
the presence of large [Ca2+]mit signals and increased reduction of
mitochondrial NAD(P)H. These results show that ARALAR-MAS is a
major contributor of Ca2+-stimulated respiration in neurons by
providing increased pyruvate supply to mitochondria. In its absence
and under moderate workloads, matrix Ca2+ is unable to stimulate
pyruvate metabolism and entry inmitochondria suggesting a limited
role of MCU in these conditions.
doi:10.1016/j.bbabio.2014.05.004
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Mitochondrial metabolism is intimately connected to the univer-
sal coenzyme NAD. In addition to its role in energy transduction,
NAD serves as a substrate in regulatory reactions that lead to its
degradation. These reactions include generation of second messen-
gers as well as posttranslational protein modiﬁcations such as ADP-
ribosylation and sirtuin-mediated protein deacetylation and occur
most prominently in the nucleus and mitochondria. In the nucleus,
ADP-ribosylation and NAD-dependent deacetylation regulate fun-
damental processes including gene expression, DNA repair and
maintenance of chromatin structure. In mitochondria, NAD-depen-
dent signaling events have a profound impact on metabolic
regulation. Many targets of mitochondrial NAD-dependent protein
deacetylation and mono-ADP-ribosylation have been identiﬁed and
important physiological consequences of the modiﬁcations have
been revealed.
Given the degradation of NAD in these reactions, maintenance of
the mitochondrial NAD pool has emerged as a key factor in the
regulation of mitochondrial metabolism. Therefore, identifying the
mechanisms of mitochondrial NAD generation in mammalian cells
has been a major research focus over the last years. We have
developed a variety of experimental tools that enable modulation of
subcellular NAD contents and detection of changes in different
compartments of cultured human cells. Using these tools, we have
studied the NAD biosynthetic pathways in human cells. Our analyses
suggest that the majority of the reactions takes place in the cytosol
and nucleus. However, one isoform of the enzymes catalyzing the
ﬁnal step of NAD synthesis is present in the mitochondrial matrix. It
requires the mononucleotide NMN, which needs to be imported
from the cytosol. Therefore, mitochondria in human cells can
establish and maintain an autonomous NAD pool. Interestingly,
changes of the NAD contents are reﬂected in the protein acetylation
state. That is, alterations of NAD pools do not only affect bioenergetic
processes, but also sirtuin-dependent protein deacetylation and thereby
critical regulatory events.
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The activity of melatonin inﬂuences almost all body cells and,
as recently recognized, with bioenergetic consequences. Our work
indicated that in HaCaT cells, melatonin administrated at physiolog-
ical concentration (HaCmel+), modulates energy production fol-
lowing a pathway involving Nitric Oxide (NO). As a signalling
molecule, NO presents a wide spectrum of targets, differently
inﬂuenced depending on the NOS isoform implicated, and on the
amount/localisation of NO produced. Our data show that in
HaCmel+ cells an increase of nNOS expression occurs, leading to
accumulation of nitrite and nitrate and consistently oxygen con-
sumption is slightly depressed. Mitochondrial complex IV is in fact
reversibly inhibited by NO, whose increase induced by melatonin
appears compatible with a “mild” OXPHOS depression, character-
istic of the physiological variation of energy demand related to
circadian rhythms [1, 2]. The issue of cell energy metabolism has
been also readdressed to the 7PA2 cell line, a model of the
Alzheimer's disease (AD). The biochemical characterisation of
7PA2 cells, expressing the mutated human APP protein, showed a
marked decrease of mitochondrial function, evaluated by measur-
ing oxygen consumption, mitochondrial membrane potential and
ATP production. The observed nitrite/nitrate accumulation points
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